undefined icon

IMVT - Keuangan

Overnight MarketOvernight Market

Immunovant, Inc. Common Stock

--
0
--
0
Belum ada data.
iconPerforma Harga
Harga kembali 1 minggu-
Harga kembali 1 Bulan-
Harga kembali 3 Bulan-
Harga kembali 6 Bulan-
Harga Tertinggi (52 Minggu)-
Harga Terendah (52 Minggu)-
Latar Belakang Perusahaan
Immunovant, Inc. is a clinical-stage biopharmaceutical company developing treatments for autoimmune diseases.

Income Statement

20262025202420232022

Total Revenue

-----

Gross Profit

(409,000)(377,000)(231,000)(1.32M)(1.23M)

Operating Income

(532.90M)(438.15M)(270.21M)(208.28M)(156.03M)

Net Income

(505.61M)(413.84M)(259.34M)(210.96M)(156.73M)

Net Margin %

-----

Saham Terkait